Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
NNMT
Introduction
Nicotinamide N-methyltransferase is an enzyme that in humans is encoded by the NNMT gene.[1][2]
N-methylation is one method by which drug and other xenobiotic compounds are metabolized by the liver. This gene encodes the protein responsible for this enzymatic activity which uses S-adenosyl methionine as the methyl donor.[2]
References
References
- ↑ Aksoy S, Brandriff BF, Ward A, Little PF, Weinshilboum RM (Mar 1996). “Human nicotinamide N-methyltransferase gene: molecular cloning, structural characterization and chromosomal localization”. Genomics. 29 (3): 555–61. doi:10.1006/geno.1995.9966. PMID 8575745.
- ↑ 2.0 2.1 “Entrez Gene: NNMT nicotinamide N-methyltransferase”.
Further reading
Further reading
- Williams AC, Cartwright LS, Ramsden DB (2005). “Parkinson’s disease: the first common neurological disease due to auto-intoxication?”. QJM : Monthly Journal of the Association of Physicians. 98 (3): 215–26. doi:10.1093/qjmed/hci027. PMID 15728403.
- Sano A, Endo N, Takitani S (1992). “Fluorometric assay of rat tissue N-methyltransferases with nicotinamide and four isomeric methylnicotinamides”. Chem. Pharm. Bull. 40 (1): 153–6. doi:10.1248/cpb.40.153. PMID 1533573.
- Aksoy S, Szumlanski CL, Weinshilboum RM (1994). “Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization”. J. Biol. Chem. 269 (20): 14835–40. PMID 8182091.
- Scheller T, Orgacka H, Szumlanski CL, Weinshilboum RM (1996). “Mouse liver nicotinamide N-methyltransferase pharmacogenetics: biochemical properties and variation in activity among inbred strains”. Pharmacogenetics. 6 (1): 43–53. doi:10.1097/00008571-199602000-00003. PMID 8845860.
- Smith ML, Burnett D, Bennett P, et al. (1998). “A direct correlation between nicotinamide N-methyltransferase activity and protein levels in human liver cytosol”. Biochim. Biophys. Acta. 1442 (2–3): 238–44. doi:10.1016/s0167-4781(98)00177-8. PMID 9804963.
- Yan L, Otterness DM, Weinshilboum RM (1999). “Human nicotinamide N-methyltransferase pharmacogenetics: gene sequence analysis and promoter characterization”. Pharmacogenetics. 9 (3): 307–16. doi:10.1097/00008571-199906000-00005. PMID 10471062.
- Hubbard MJ, McHugh NJ (2001). “Human ERp29: isolation, primary structural characterisation and two-dimensional gel mapping”. Electrophoresis. 21 (17): 3785–96. doi:10.1002/1522-2683(200011)21:17<3785::AID-ELPS3785>3.0.CO;2-2. PMID 11271497.
- Parsons RB, Smith ML, Williams AC, et al. (2002). “Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain”. J. Neuropathol. Exp. Neurol. 61 (2): 111–24. PMID 11853016.
- Kassem HSh, Sangar V, Cowan R, et al. (2002). “A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer”. Int. J. Cancer. 101 (5): 454–60. doi:10.1002/ijc.10631. PMID 12216074.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Xu J, Capezzone M, Xu X, Hershman JM (2005). “Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells”. Mol. Endocrinol. 19 (2): 527–39. doi:10.1210/me.2004-0215. PMID 15486044.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Souto JC, Blanco-Vaca F, Soria JM, et al. (2005). “A Genomewide Exploration Suggests a New Candidate Gene at Chromosome 11q23 as the Major Determinant of Plasma Homocysteine Levels: Results from the GAIT Project”. Am. J. Hum. Genet. 76 (6): 925–33. doi:10.1086/430409. PMC 1196452. PMID 15849667.
- Roessler M, Rollinger W, Palme S, et al. (2005). “Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer”. Clin. Cancer Res. 11 (18): 6550–7. doi:10.1158/1078-0432.CCR-05-0983. PMID 16166432.
- Xu J, Hershman JM (2006). “Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells”. Thyroid. 16 (2): 151–60. doi:10.1089/thy.2006.16.151. PMID 16676400.